179 related articles for article (PubMed ID: 28337469)
21. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra.
Brenner M; Ruzicka T; Plewig G; Thomas P; Herzer P
Br J Dermatol; 2009 Nov; 161(5):1199-201. PubMed ID: 19673875
[TBL] [Abstract][Full Text] [Related]
22. Imaging findings of sterile pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome: differential diagnosis and review of the literature.
Martinez-Rios C; Jariwala MP; Highmore K; Duffy KW; Spiegel L; Laxer RM; Stimec J
Pediatr Radiol; 2019 Jan; 49(1):23-36. PubMed ID: 30225645
[TBL] [Abstract][Full Text] [Related]
23. Synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome: a brief review of a rare condition.
Koh ET
Ann Acad Med Singap; 1998 Jan; 27(1):122-4. PubMed ID: 9588288
[TBL] [Abstract][Full Text] [Related]
24. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
Bruzzese V
J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
[TBL] [Abstract][Full Text] [Related]
25. Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report.
McKenzie SA; Ni CS; Hsiao JL
Cureus; 2019 Jun; 11(6):e4970. PubMed ID: 31453042
[TBL] [Abstract][Full Text] [Related]
26. Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab).
Flora A; Holland R; Smith A; Frew JW
JAAD Case Rep; 2021 Aug; 14():33-36. PubMed ID: 34258349
[No Abstract] [Full Text] [Related]
27. Periodic Fever: A Review on Clinical, Management and Guideline for Iranian Patients - Part II.
Ahmadinejad Z; Mansouri S; Ziaee V; Aghighi Y; Moradinejad MH; Fereshteh-Mehregan F
Iran J Pediatr; 2014 Jun; 24(3):229-40. PubMed ID: 25562014
[TBL] [Abstract][Full Text] [Related]
28. Acne-associated syndromes: models for better understanding of acne pathogenesis.
Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
[TBL] [Abstract][Full Text] [Related]
29. [Targeted therapy of pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome (PAPA): a case report and literature review].
Liang WL; Li HG; Zhong G; Wang BS; Ma JD; Chen JL; Mao HW; Yu-Lung YL; Lee PH
Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):977-981. PubMed ID: 33256319
[No Abstract] [Full Text] [Related]
30. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update.
Liu S; Tang M; Cao Y; Li C
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20912865. PubMed ID: 32523634
[TBL] [Abstract][Full Text] [Related]
31. Neutrophilic dermatoses in children.
Berk DR; Bayliss SJ
Pediatr Dermatol; 2008; 25(5):509-19. PubMed ID: 18950391
[TBL] [Abstract][Full Text] [Related]
32. Synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome in childhood: a report of ten cases and review of the literature.
Beretta-Piccoli BC; Sauvain MJ; Gal I; Schibler A; Saurenmann T; Kressebuch H; Bianchetti MG
Eur J Pediatr; 2000 Aug; 159(8):594-601. PubMed ID: 10968238
[TBL] [Abstract][Full Text] [Related]
33. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
Vekic DA; Woods J; Lin P; Cains GD
Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
[TBL] [Abstract][Full Text] [Related]
34. A novel de novo PSTPIP1 mutation in a boy with pyogenic arthritis, pyoderma gangrenosum, acne (PAPA) syndrome.
Fathalla BM; Al-Wahadneh AM; Al-Mutawa M; Kambouris M; El-Shanti H
Clin Exp Rheumatol; 2014; 32(6):956-8. PubMed ID: 24960411
[TBL] [Abstract][Full Text] [Related]
35. New insights into pustular dermatoses in pediatric patients.
Posso-De Los Rios CJ; Pope E
J Am Acad Dermatol; 2014 Apr; 70(4):767-773. PubMed ID: 24388422
[TBL] [Abstract][Full Text] [Related]
36. PAPA spectrum disorders.
Genovese G; Moltrasio C; Garcovich S; Marzano AV
G Ital Dermatol Venereol; 2020 Oct; 155(5):542-550. PubMed ID: 32618443
[TBL] [Abstract][Full Text] [Related]
37. Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome: differential diagnosis of septic arthritis by regular detection of exceedingly high synovial cell counts.
Löffler W; Lohse P; Weihmayr T; Widenmayer W
Infection; 2017 Aug; 45(4):395-402. PubMed ID: 28251506
[TBL] [Abstract][Full Text] [Related]
38. Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab.
Nikolakis G; Kreibich K; Vaiopoulos A; Kaleta K; Talas J; Becker M; Zouboulis CC
F1000Res; 2021; 10():381. PubMed ID: 34540202
[TBL] [Abstract][Full Text] [Related]
39. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.
Lindor NM; Arsenault TM; Solomon H; Seidman CE; McEvoy MT
Mayo Clin Proc; 1997 Jul; 72(7):611-5. PubMed ID: 9212761
[TBL] [Abstract][Full Text] [Related]
40. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment.
Cugno M; Borghi A; Marzano AV
Am J Clin Dermatol; 2017 Aug; 18(4):555-562. PubMed ID: 28236224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
